Opthea (ASX:OPT) Share Price and News

Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company's lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in South Yarra, Australia.

Expand Company Description

Market Cap (10-Oct) $1,083,359,232 (468th)	Close (30-Jun) $0.55 0 (0%)	Volume (30-Jun) 827,047	Shortsold (23-Sep) 8,645,511 (0.70%) (256th)
52w High $0.90	52w Low $0.290	P/E 6.75	EPS -0.51

	Subject
	OPT OPT Ann: Change in substantial holding
	1 (current) 2 3
	OPT OPT Ann: Final Director's Interest Notice MS
	OPT OPT Ann: Initial Director's Interest Notice AT
	OPT OPT Ann: Opthea Appoints Anshul Thakral as Non-Executive Director
	OPT OPT Ann: Ceasing to be a substantial holder
	OPT OPT Ann: Opthea Presents at the Jefferies 2023 Healthcare Conference
	OPT OPT Ann: Opthea participates in EF Hutton hosted webinar on OPT-302
	OPT OPT Ann: Change in substantial holding
	OPT OPT Ann: Opthea Presents at JMP Securities Life Sciences Conference
	OPT OPT Ann: Opthea to Participate at HC Wainwright BioConnect Conference
	OPT OPT Ann: Becoming a substantial holder
	OPT OPT Ann: Opthea Receives A$8.7million R&D Tax Incentive
	OPT OPT Ann: Opthea to participate at Oppenheimer's Healthcare Conference
	OPT OPT Ann: Half Year Accounts
	OPT OPT Ann: Response to ASX Query
	OPT OPT Ann: Opthea Ph2b Trial Results with OPT-302 published in Journal
	OPT OPT Ann: Appendix 2A
	OPT OPT Ann: Opthea to present at SVB Leerink Global Biopharma Conference
	OPT OPT Ann: Opthea to Present at Sequire Biotechnology Conference
	OPT OPT Ann: Opthea Corporate Presentation - San Francisco Jan 2023
	OPT OPT Ann: Opthea Announces MST Conference call with Jason Slakter MD
	OPT OPT Ann: Opthea to present at the FLORetina 2022 Congress
	OPT OPT Ann: Cleansing Notice
	OPT OPT Ann: Appendix 2A
	OPT OPT Ann: Appendix 2A
	OPT OPT Ann: Cleansing Notice
	OPT OPT Ann: Appendix 3Y MS
	OPT OPT Ann: Appendix 3Y MB
	OPT OPT Ann: Notification regarding unquoted securities - OPT
	OPT OPT Ann: Notification regarding unquoted securities - OPT
	OPT OPT Ann: Notification regarding unquoted securities - OPT
	OPT OPT Ann: Results of Meeting
	OPT OPT Ann: Chairman's Address to Shareholders
	OPT OPT Ann: Opthea to Present at Jefferies London Healthcare Conference
	OPT OPT Ann: Appendix 2A
	OPT OPT Ann: Cleansing Notice
	OPT OPT Ann: Opthea Expands Leadership Team with CFO Appointment
	OPT OPT Ann: Notice of General Meeting/Proxy Form
	OPT OPT Ann: Change in substantial holding
	OPT OPT Ann: Change in substantial holding
	OPT OPT Ann: Cleansing Notice
	OPT OPT Ann: Application for quotation of securities - OPT
	OPT OPT Ann: Results of Meeting
	OPT OPT Ann: Application for quotation of securities - OPT
	OPT OPT Ann: Completion of Share Purchase Plan
	OPT OPT Ann: Opthea Appendix 4G Corporate Governance Statement 2022
	OPT OPT Ann: Opthea reports Fiscal Year 2022 Results and Highlights
	OPT OPT Ann: Opthea Appendix 4E and Annual Report 2022
	OPT OPT Ann: Change in substantial holding
	OPT OPT Ann: Change in substantial holding

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
10-Oct	$0.88	3,303,046	+0.01 (0.57%)
09-Oct	$0.87	4,510,066	-0.01 (1.14%)
08-Oct	$0.88	3,692,961	-0.02 (1.68%)
07-Oct	$0.90	3,729,639	+0.07 (8.48%)
04-Oct	$0.83	3,483,241	0.00 (0.00%)
03-Oct	$0.83	3,473,428	+0.01 (1.85%)
02-Oct	$0.81	4,042,927	-0.02 (2.41%)
01-Oct	$0.83	4,249,677	+0.05 (7.10%)
30-Sep	$0.78	4,274,571	+0.18 (30.25%)
11-Sep	$0.60	18,988,861	-0.02 (2.46%)
10-Sep	$0.61	2,563,347	0.00 (0.00%)
09-Sep	$0.61	5,637,346	+0.08 (14.02%)
06-Sep	$0.54	1,527,800	-0.02 (2.73%)
05-Sep	$0.55	1,646,143	0.00 (0.00%)
04-Sep	$0.55	1,077,330	-0.01 (2.65%)
6 up, 6 down, and 3 flat days

High $0.56	Low $0.54	Trades 245	Turnover $454,189	Volume 827,047
30 June 2023 at 4:59pm

High $0.56	Low $0.54	Trades 245	Turnover $454,189	Volume 827,047
30 June 2023 at 4:59pm

Opthea Health Care

$0.550 0.010 (1.85%)

$0.550 0.010 (1.85%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices